Results 271 to 280 of about 241,371 (303)

Nonpegylated Liposomal Doxorubicin (Myocet™) Combination (R-COMP) Chemotherapy in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase II EUR018 Trial

Annals of Oncology, 2010
Stefano Luminari, Annalisa Chiappella, Morena Petrini   +2 more
exaly  

Doxorubicin

Reactions Weekly, 2021
openaire   +1 more source

Comparison of Pixantrone-Based Regimen (CPOP-R) With Doxorubicin-Based Therapy (CHOP-R) for Treatment of Diffuse Large B-Cell Lymphoma

Annals of Oncology, 2013
Raoul Herbrecht, Jack W. Singer, S le Gouill   +2 more
exaly  

Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy

Circulation Research, 2020
Vilma A. Sardão, Kendall Wallace, Paulo J. Oliveira   +2 more
exaly  

Doxorubicin see Epirubicin/doxorubicin

Reactions, 1988
openaire   +1 more source

Carfilzomib/doxorubicin/doxorubicin liposomal

Reactions Weekly, 2015
openaire   +1 more source

Olaratumab and Doxorubicin Versus Doxorubicin Alone for Treatment of Soft-Tissue Sarcoma: An Open-Label Phase 1b and Randomised Phase 2 Trial

Lancet, The, 2016
William D Tap, Anthony D Elias, Mark Agulnik   +2 more
exaly  

Doxorubicin

Reactions Weekly, 2015
  +4 more sources

Folate-Receptor-Targeted Delivery of Doxorubicin Nano-Aggregates Stabilized by Doxorubicin–PEG–Folate Conjugate

Journal of Controlled Release, 2004
Hyuksang Yoo, Tae Gwan Park
exaly  

Chitosan-Based Nanoparticles as Drug Delivery Systems for Doxorubicin: Optimization and Modelling

Carbohydrate Polymers, 2016
Jorge C Silva, João P. Borges, Paula I P Soares   +2 more
exaly